Industry Research Reports
Home > Reports > Pharma & Healthcare > Dry Powder Inhalation Excipients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Dry Powder Inhalation Excipients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Pharma & Healthcare
Published Date: 2026-01-19
Pages: 123 Pages
Report ld: 5778521
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Dry Powder Inhalation Excipients Market Size(US$)
CAGR 2026-2032
5.4%
Market Size,2032
USD 2,613
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 1,906 million
Market Forecast in 2032(Value)
US$ 2,613 million
CAGR
5.4%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1817 million in 2025 and is projected to reach US$ 2613 million, growing at a CAGR of 5.4% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Dry Powder Inhalation Excipients cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Dry powder inhalation excipients are auxiliary components used in dry powder inhalation formulations to improve drug dispersion, stability, and inhalation performance. They typically include lactose, mannitol, and other sugars, as well as certain inorganic salts. By optimizing the particle size and distribution of the drug, these excipients enhance the lung deposition rate and bioavailability of the drug. Dry powder inhalation excipients play a crucial role in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease, ensuring effective drug inhalation and therapeutic effects.
The North American market for Dry Powder Inhalation Excipients was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Dry Powder Inhalation Excipients was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Dry Powder Inhalation Excipients was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Dry Powder Inhalation Excipients market include Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, Sheffield (Kerry), Armor Pharma, Abbott, Norvatis, Bayer, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Dry Powder Inhalation Excipients, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Dry Powder Inhalation Excipients market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Dry Powder Inhalation Excipients.
MARKET SEGMENTATION
By Company
- Protheragen-ING
- DFE Pharma
- Meggle-Pharma
- Pfanstiehl
- Merck
- Sheffield (Kerry)
- Armor Pharma
- Abbott
- Norvatis
- Bayer
- Jiangsu Daoning Drug
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Lactose
- Magnesium Stearate
- Others
Segment by Application
- DPI
- MDI
- Nebulizer
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Dry Powder Inhalation Excipients manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Dry Powder Inhalation Excipients sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Dry Powder Inhalation Excipients sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Dry Powder Inhalation Excipients Product Introduction
1.2 Global Dry Powder Inhalation Excipients Market Size Forecast
1.2.1 Global Dry Powder Inhalation Excipients Sales Value (2021–2032)
1.2.2 Global Dry Powder Inhalation Excipients Sales Volume (2021–2032)
1.2.3 Global Dry Powder Inhalation Excipients Sales Price (2021–2032)
1.3 Dry Powder Inhalation Excipients Market Trends & Drivers
1.3.1 Dry Powder Inhalation Excipients Industry Trends
1.3.2 Dry Powder Inhalation Excipients Market Drivers & Opportunities
1.3.3 Dry Powder Inhalation Excipients Market Challenges
1.3.4 Dry Powder Inhalation Excipients Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dry Powder Inhalation Excipients Players Revenue Ranking (2025)
2.2 Global Dry Powder Inhalation Excipients Revenue by Company (2021–2026)
2.3 Global Dry Powder Inhalation Excipients Sales Volume Ranking of Players (2025)
2.4 Global Dry Powder Inhalation Excipients Sales Volume by Company (2021–2026)
2.5 Global Dry Powder Inhalation Excipients Average Price by Company (2021–2026)
2.6 Key Manufacturers Dry Powder Inhalation Excipients Manufacturing Base and Headquarters
2.7 Key Manufacturers Dry Powder Inhalation Excipients Product Offerings
2.8 Key Manufacturers Start of Mass Production of Dry Powder Inhalation Excipients
2.9 Dry Powder Inhalation Excipients Market Competitive Analysis
2.9.1 Dry Powder Inhalation Excipients Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Dry Powder Inhalation Excipients Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dry Powder Inhalation Excipients revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Dry Powder Inhalation Excipients Market Classification
3.1 Introduction by Type
3.1.1 Lactose
3.1.2 Magnesium Stearate
3.1.3 Others
3.1.4 Global Dry Powder Inhalation Excipients Sales Value by Type
3.1.4.1 Global Dry Powder Inhalation Excipients Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Dry Powder Inhalation Excipients Sales Value, by Type (2021–2032)
3.1.4.3 Global Dry Powder Inhalation Excipients Sales Value, by Type (%), 2021–2032
3.1.5 Global Dry Powder Inhalation Excipients Sales Volume by Type
3.1.5.1 Global Dry Powder Inhalation Excipients Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Dry Powder Inhalation Excipients Sales Volume, by Type (2021–2032)
3.1.5.3 Global Dry Powder Inhalation Excipients Sales Volume, by Type (%), 2021–2032
3.1.6 Global Dry Powder Inhalation Excipients Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 DPI
4.1.2 MDI
4.1.3 Nebulizer
4.1.4 Others
4.2 Global Dry Powder Inhalation Excipients Sales Value by Application
4.2.1 Global Dry Powder Inhalation Excipients Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Dry Powder Inhalation Excipients Sales Value, by Application (2021–2032)
4.2.3 Global Dry Powder Inhalation Excipients Sales Value, by Application (%), 2021–2032
4.3 Global Dry Powder Inhalation Excipients Sales Volume by Application
4.3.1 Global Dry Powder Inhalation Excipients Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Dry Powder Inhalation Excipients Sales Volume, by Application (2021–2032)
4.3.3 Global Dry Powder Inhalation Excipients Sales Volume, by Application (%), 2021–2032
4.4 Global Dry Powder Inhalation Excipients Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Dry Powder Inhalation Excipients Sales Value by Region
5.1.1 Global Dry Powder Inhalation Excipients Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Dry Powder Inhalation Excipients Sales Value by Region (2021–2026)
5.1.3 Global Dry Powder Inhalation Excipients Sales Value by Region (2027–2032)
5.1.4 Global Dry Powder Inhalation Excipients Sales Value by Region (%), 2021–2032
5.2 Global Dry Powder Inhalation Excipients Sales Volume by Region
5.2.1 Global Dry Powder Inhalation Excipients Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Dry Powder Inhalation Excipients Sales Volume by Region (2021–2026)
5.2.3 Global Dry Powder Inhalation Excipients Sales Volume by Region (2027–2032)
5.2.4 Global Dry Powder Inhalation Excipients Sales Volume by Region (%), 2021–2032
5.3 Global Dry Powder Inhalation Excipients Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Dry Powder Inhalation Excipients Sales Value, 2021–2032
5.4.2 North America Dry Powder Inhalation Excipients Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Dry Powder Inhalation Excipients Sales Value, 2021–2032
5.5.2 Europe Dry Powder Inhalation Excipients Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Dry Powder Inhalation Excipients Sales Value, 2021–2032
5.6.2 Asia Pacific Dry Powder Inhalation Excipients Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Dry Powder Inhalation Excipients Sales Value, 2021–2032
5.7.2 South America Dry Powder Inhalation Excipients Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dry Powder Inhalation Excipients Sales Value, 2021–2032
5.8.2 Middle East & Africa Dry Powder Inhalation Excipients Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dry Powder Inhalation Excipients Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Dry Powder Inhalation Excipients Sales Value and Sales Volume
6.2.1 Key Countries/Regions Dry Powder Inhalation Excipients Sales Value, 2021–2032
6.2.2 Key Countries/Regions Dry Powder Inhalation Excipients Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Dry Powder Inhalation Excipients Sales Value, 2021–2032
6.3.2 United States Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Dry Powder Inhalation Excipients Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Dry Powder Inhalation Excipients Sales Value, 2021–2032
6.4.2 Europe Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Dry Powder Inhalation Excipients Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Dry Powder Inhalation Excipients Sales Value, 2021–2032
6.5.2 China Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
6.5.3 China Dry Powder Inhalation Excipients Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Dry Powder Inhalation Excipients Sales Value, 2021–2032
6.6.2 Japan Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Dry Powder Inhalation Excipients Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Dry Powder Inhalation Excipients Sales Value, 2021–2032
6.7.2 South Korea Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Dry Powder Inhalation Excipients Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Dry Powder Inhalation Excipients Sales Value, 2021–2032
6.8.2 Southeast Asia Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Dry Powder Inhalation Excipients Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Dry Powder Inhalation Excipients Sales Value, 2021–2032
6.9.2 India Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
6.9.3 India Dry Powder Inhalation Excipients Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Protheragen-ING
7.1.1 Protheragen-ING Company Information
7.1.2 Protheragen-ING Introduction and Business Overview
7.1.3 Protheragen-ING Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Protheragen-ING Dry Powder Inhalation Excipients Product Offerings
7.1.5 Protheragen-ING Recent Developments
7.2 DFE Pharma
7.2.1 DFE Pharma Company Information
7.2.2 DFE Pharma Introduction and Business Overview
7.2.3 DFE Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 DFE Pharma Dry Powder Inhalation Excipients Product Offerings
7.2.5 DFE Pharma Recent Developments
7.3 Meggle-Pharma
7.3.1 Meggle-Pharma Company Information
7.3.2 Meggle-Pharma Introduction and Business Overview
7.3.3 Meggle-Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Meggle-Pharma Dry Powder Inhalation Excipients Product Offerings
7.3.5 Meggle-Pharma Recent Developments
7.4 Pfanstiehl
7.4.1 Pfanstiehl Company Information
7.4.2 Pfanstiehl Introduction and Business Overview
7.4.3 Pfanstiehl Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Pfanstiehl Dry Powder Inhalation Excipients Product Offerings
7.4.5 Pfanstiehl Recent Developments
7.5 Merck
7.5.1 Merck Company Information
7.5.2 Merck Introduction and Business Overview
7.5.3 Merck Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Merck Dry Powder Inhalation Excipients Product Offerings
7.5.5 Merck Recent Developments
7.6 Sheffield (Kerry)
7.6.1 Sheffield (Kerry) Company Information
7.6.2 Sheffield (Kerry) Introduction and Business Overview
7.6.3 Sheffield (Kerry) Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Sheffield (Kerry) Dry Powder Inhalation Excipients Product Offerings
7.6.5 Sheffield (Kerry) Recent Developments
7.7 Armor Pharma
7.7.1 Armor Pharma Company Information
7.7.2 Armor Pharma Introduction and Business Overview
7.7.3 Armor Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Armor Pharma Dry Powder Inhalation Excipients Product Offerings
7.7.5 Armor Pharma Recent Developments
7.8 Abbott
7.8.1 Abbott Company Information
7.8.2 Abbott Introduction and Business Overview
7.8.3 Abbott Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Abbott Dry Powder Inhalation Excipients Product Offerings
7.8.5 Abbott Recent Developments
7.9 Norvatis
7.9.1 Norvatis Company Information
7.9.2 Norvatis Introduction and Business Overview
7.9.3 Norvatis Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Norvatis Dry Powder Inhalation Excipients Product Offerings
7.9.5 Norvatis Recent Developments
7.10 Bayer
7.10.1 Bayer Company Information
7.10.2 Bayer Introduction and Business Overview
7.10.3 Bayer Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Bayer Dry Powder Inhalation Excipients Product Offerings
7.10.5 Bayer Recent Developments
7.11 Jiangsu Daoning Drug
7.11.1 Jiangsu Daoning Drug Company Information
7.11.2 Jiangsu Daoning Drug Introduction and Business Overview
7.11.3 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product Offerings
7.11.5 Jiangsu Daoning Drug Recent Developments
8 Industry Chain Analysis
8.1 Dry Powder Inhalation Excipients Industrial Chain
8.2 Dry Powder Inhalation Excipients Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Dry Powder Inhalation Excipients Sales Model
8.5.2 Sales Channels
8.5.3 Dry Powder Inhalation Excipients Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Dry Powder Inhalation Excipients Market Trends
Table 2. Dry Powder Inhalation Excipients Market Drivers & Opportunities
Table 3. Dry Powder Inhalation Excipients Market Challenges
Table 4. Dry Powder Inhalation Excipients Market Restraints
Table 5. Global Dry Powder Inhalation Excipients Revenue by Company (US$ Million), 2021–2026
Table 6. Global Dry Powder Inhalation Excipients Revenue Market Share by Company (2021–2026)
Table 7. Global Dry Powder Inhalation Excipients Sales Volume by Company (Tons), 2021–2026
Table 8. Global Dry Powder Inhalation Excipients Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Dry Powder Inhalation Excipients Price by Company (US$/Ton), 2021–2026
Table 10. Key Manufacturers Dry Powder Inhalation Excipients Manufacturing Base and Headquarters
Table 11. Key Manufacturers Dry Powder Inhalation Excipients Product Type
Table 12. Key Manufacturers Start of Mass Production of Dry Powder Inhalation Excipients
Table 13. Global Dry Powder Inhalation Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Dry Powder Inhalation Excipients revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Dry Powder Inhalation Excipients Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Dry Powder Inhalation Excipients Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Dry Powder Inhalation Excipients Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Dry Powder Inhalation Excipients Sales Market Share in Value by Type (2021–2026)
Table 20. Global Dry Powder Inhalation Excipients Sales Market Share in Value by Type (2027–2032)
Table 21. Global Dry Powder Inhalation Excipients Sales Volume by Type: 2021 vs 2025 vs 2032 (Tons)
Table 22. Global Dry Powder Inhalation Excipients Sales Volume by Type (Tons), 2021–2026
Table 23. Global Dry Powder Inhalation Excipients Sales Volume by Type (Tons), 2027–2032
Table 24. Global Dry Powder Inhalation Excipients Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Dry Powder Inhalation Excipients Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Dry Powder Inhalation Excipients Price by Type (US$/Ton), 2021–2026
Table 27. Global Dry Powder Inhalation Excipients Price by Type (US$/Ton), 2027–2032
Table 28. Global Dry Powder Inhalation Excipients Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Dry Powder Inhalation Excipients Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Dry Powder Inhalation Excipients Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Dry Powder Inhalation Excipients Sales Market Share in Value by Application (2021–2026)
Table 32. Global Dry Powder Inhalation Excipients Sales Market Share in Value by Application (2027–2032)
Table 33. Global Dry Powder Inhalation Excipients Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons)
Table 34. Global Dry Powder Inhalation Excipients Sales Volume by Application (Tons), 2021–2026
Table 35. Global Dry Powder Inhalation Excipients Sales Volume by Application (Tons), 2027–2032
Table 36. Global Dry Powder Inhalation Excipients Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Dry Powder Inhalation Excipients Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Dry Powder Inhalation Excipients Price by Application (US$/Ton), 2021–2026
Table 39. Global Dry Powder Inhalation Excipients Price by Application (US$/Ton), 2027–2032
Table 40. Global Dry Powder Inhalation Excipients Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Dry Powder Inhalation Excipients Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Dry Powder Inhalation Excipients Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Dry Powder Inhalation Excipients Sales Value by Region (%), 2021–2026
Table 44. Global Dry Powder Inhalation Excipients Sales Value by Region (%), 2027–2032
Table 45. Global Dry Powder Inhalation Excipients Sales Volume by Region (Tons): 2021 vs 2025 vs 2032
Table 46. Global Dry Powder Inhalation Excipients Sales Volume by Region (Tons), 2021–2026
Table 47. Global Dry Powder Inhalation Excipients Sales Volume by Region (Tons), 2027–2032
Table 48. Global Dry Powder Inhalation Excipients Sales Volume by Region (%), 2021–2026
Table 49. Global Dry Powder Inhalation Excipients Sales Volume by Region (%), 2027–2032
Table 50. Global Dry Powder Inhalation Excipients Average Price by Region (US$/Ton), 2021–2026
Table 51. Global Dry Powder Inhalation Excipients Average Price by Region (US$/Ton), 2027–2032
Table 52. Key Countries/Regions Dry Powder Inhalation Excipients Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Dry Powder Inhalation Excipients Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Dry Powder Inhalation Excipients Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Dry Powder Inhalation Excipients Sales Volume, (Tons), 2021–2026
Table 56. Key Countries/Regions Dry Powder Inhalation Excipients Sales Volume, (Tons), 2027–2032
Table 57. Protheragen-ING Company Information
Table 58. Protheragen-ING Introduction and Business Overview
Table 59. Protheragen-ING Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 60. Protheragen-ING Dry Powder Inhalation Excipients Product Offerings
Table 61. Protheragen-ING Recent Developments
Table 62. DFE Pharma Company Information
Table 63. DFE Pharma Introduction and Business Overview
Table 64. DFE Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 65. DFE Pharma Dry Powder Inhalation Excipients Product Offerings
Table 66. DFE Pharma Recent Developments
Table 67. Meggle-Pharma Company Information
Table 68. Meggle-Pharma Introduction and Business Overview
Table 69. Meggle-Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 70. Meggle-Pharma Dry Powder Inhalation Excipients Product Offerings
Table 71. Meggle-Pharma Recent Developments
Table 72. Pfanstiehl Company Information
Table 73. Pfanstiehl Introduction and Business Overview
Table 74. Pfanstiehl Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 75. Pfanstiehl Dry Powder Inhalation Excipients Product Offerings
Table 76. Pfanstiehl Recent Developments
Table 77. Merck Company Information
Table 78. Merck Introduction and Business Overview
Table 79. Merck Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 80. Merck Dry Powder Inhalation Excipients Product Offerings
Table 81. Merck Recent Developments
Table 82. Sheffield (Kerry) Company Information
Table 83. Sheffield (Kerry) Introduction and Business Overview
Table 84. Sheffield (Kerry) Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 85. Sheffield (Kerry) Dry Powder Inhalation Excipients Product Offerings
Table 86. Sheffield (Kerry) Recent Developments
Table 87. Armor Pharma Company Information
Table 88. Armor Pharma Introduction and Business Overview
Table 89. Armor Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 90. Armor Pharma Dry Powder Inhalation Excipients Product Offerings
Table 91. Armor Pharma Recent Developments
Table 92. Abbott Company Information
Table 93. Abbott Introduction and Business Overview
Table 94. Abbott Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 95. Abbott Dry Powder Inhalation Excipients Product Offerings
Table 96. Abbott Recent Developments
Table 97. Norvatis Company Information
Table 98. Norvatis Introduction and Business Overview
Table 99. Norvatis Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 100. Norvatis Dry Powder Inhalation Excipients Product Offerings
Table 101. Norvatis Recent Developments
Table 102. Bayer Company Information
Table 103. Bayer Introduction and Business Overview
Table 104. Bayer Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 105. Bayer Dry Powder Inhalation Excipients Product Offerings
Table 106. Bayer Recent Developments
Table 107. Jiangsu Daoning Drug Company Information
Table 108. Jiangsu Daoning Drug Introduction and Business Overview
Table 109. Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 110. Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product Offerings
Table 111. Jiangsu Daoning Drug Recent Developments
Table 112. Key Raw Materials Lists
Table 113. Key Suppliers of Raw Materials Lists
Table 114. Dry Powder Inhalation Excipients Downstream Customers
Table 115. Dry Powder Inhalation Excipients Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Dry Powder Inhalation Excipients Product Picture
Figure 2. Global Dry Powder Inhalation Excipients Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 4. Global Dry Powder Inhalation Excipients Sales Volume (Tons), 2021–2032
Figure 5. Global Dry Powder Inhalation Excipients Sales Price (US$/Ton), 2021–2032
Figure 6. Dry Powder Inhalation Excipients Report Years Considered
Figure 7. Global Dry Powder Inhalation Excipients Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Dry Powder Inhalation Excipients Sales Volume Ranking of Players (Tons), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dry Powder Inhalation Excipients Revenue in 2025
Figure 10. Dry Powder Inhalation Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Lactose Picture
Figure 12. Magnesium Stearate Picture
Figure 13. Others Picture
Figure 14. Global Dry Powder Inhalation Excipients Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Dry Powder Inhalation Excipients Sales Value Market Share by Type, 2025 & 2032
Figure 16. Global Dry Powder Inhalation Excipients Sales Volume by Type (Tons), 2021 vs 2025 vs 2032
Figure 17. Global Dry Powder Inhalation Excipients Sales Volume Market Share by Type, 2025 & 2032
Figure 18. Global Dry Powder Inhalation Excipients Price by Type (US$/Ton), 2021–2032
Figure 19. Product Picture of DPI
Figure 20. Product Picture of MDI
Figure 21. Product Picture of Nebulizer
Figure 22. Product Picture of Others
Figure 23. Global Dry Powder Inhalation Excipients Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Dry Powder Inhalation Excipients Sales Value Market Share by Application, 2025 & 2032
Figure 25. Global Dry Powder Inhalation Excipients Sales Volume by Application (Tons), 2021 vs 2025 vs 2032
Figure 26. Global Dry Powder Inhalation Excipients Sales Volume Market Share by Application, 2025 & 2032
Figure 27. Global Dry Powder Inhalation Excipients Price by Application (US$/Ton), 2021–2032
Figure 28. North America Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 29. North America Dry Powder Inhalation Excipients Sales Value by Country (%), 2025 vs 2032
Figure 30. Europe Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 31. Europe Dry Powder Inhalation Excipients Sales Value by Country (%), 2025 vs 2032
Figure 32. Asia Pacific Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 33. Asia Pacific Dry Powder Inhalation Excipients Sales Value by Region (%), 2025 vs 2032
Figure 34. South America Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 35. South America Dry Powder Inhalation Excipients Sales Value by Country (%), 2025 vs 2032
Figure 36. Middle East & Africa Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 37. Middle East & Africa Dry Powder Inhalation Excipients Sales Value by Country (%), 2025 vs 2032
Figure 38. Key Countries/Regions Dry Powder Inhalation Excipients Sales Value (%), 2021–2032
Figure 39. Key Countries/Regions Dry Powder Inhalation Excipients Sales Volume (%), 2021–2032
Figure 40. United States Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 41. United States Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
Figure 42. United States Dry Powder Inhalation Excipients Sales Value by Application (%), 2025 vs 2032
Figure 43. Europe Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 44. Europe Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
Figure 45. Europe Dry Powder Inhalation Excipients Sales Value by Application (%), 2025 vs 2032
Figure 46. China Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 47. China Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
Figure 48. China Dry Powder Inhalation Excipients Sales Value by Application (%), 2025 vs 2032
Figure 49. Japan Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 50. Japan Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
Figure 51. Japan Dry Powder Inhalation Excipients Sales Value by Application (%), 2025 vs 2032
Figure 52. South Korea Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 53. South Korea Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
Figure 54. South Korea Dry Powder Inhalation Excipients Sales Value by Application (%), 2025 vs 2032
Figure 55. Southeast Asia Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 56. Southeast Asia Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
Figure 57. Southeast Asia Dry Powder Inhalation Excipients Sales Value by Application (%), 2025 vs 2032
Figure 58. India Dry Powder Inhalation Excipients Sales Value (US$ Million), 2021–2032
Figure 59. India Dry Powder Inhalation Excipients Sales Value by Type (%), 2025 vs 2032
Figure 60. India Dry Powder Inhalation Excipients Sales Value by Application (%), 2025 vs 2032
Figure 61. Dry Powder Inhalation Excipients Industrial Chain
Figure 62. Dry Powder Inhalation Excipients Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 5.4% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Dry Powder Inhalation Excipients market size from 2026 to 2032?
What was the global market size of Dry Powder Inhalation Excipients in 2026?
What was the global market size of Dry Powder Inhalation Excipients in 2032?
Which companies rank high in the global Dry Powder Inhalation Excipients market?
Related Reports
Global Dry Powder Inhalation Excipients Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1817 million in 2025 to US$ 2613 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 159
USD 4900.00
(Single User License)
Global Dry Powder Inhalation Excipients Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Dry Powder Inhalation Excipients market size was US$ 1817 million in 2025 and is forecast to reach a readjusted size of US$ 2613 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 99
USD 4250.00
(Single User License)
Global Dry Powder Inhalation Excipients Market Research Report 2026
The global Dry Powder Inhalation Excipients market was valued at US$ 1817 million in 2025 and is anticipated to reach US$ 2613 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 124
USD 2900.00
(Single User License)
Global Dry Powder Inhalation Excipients Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1733 million in 2024 to US$ 2491 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 159
USD 4900.00
(Single User License)
Global Dry Powder Inhalation Excipients Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dry Powder Inhalation Excipients market size was US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 92
USD 4250.00
(Single User License)
Dry Powder Inhalation Excipients - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 127
USD 3950.00
(Single User License)
Global Dry Powder Inhalation Excipients Market Research Report 2025
The global market for Dry Powder Inhalation Excipients was valued at US$ 1733 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-03-13
Pages: 97
USD 2900.00
(Single User License)
Global and United States Dry Powder Inhalation Excipients Market Report & Forecast 2024-2030
The global Dry Powder Inhalation Excipients revenue was US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 133
USD 4350.00
(Single User License)
Global Dry Powder Inhalation Excipients Market Research Report 2024
The global market for Dry Powder Inhalation Excipients was valued at US$ 1674 million in the year 2023 and is projected to reach a revised size of US$ 2376 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-01-01
Pages: 91
USD 2900.00
(Single User License)
Dry Powder Inhalation Excipients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 117
USD 3950.00
(Single User License)
Global Dry Powder Inhalation Excipients Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1817 million in 2025 to US$ 2613 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 159
USD 4900.00 (Single User License)Global Dry Powder Inhalation Excipients Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Dry Powder Inhalation Excipients market size was US$ 1817 million in 2025 and is forecast to reach a readjusted size of US$ 2613 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 99
USD 4250.00 (Single User License)Global Dry Powder Inhalation Excipients Market Research Report 2026
The global Dry Powder Inhalation Excipients market was valued at US$ 1817 million in 2025 and is anticipated to reach US$ 2613 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-01-08
Pages: 124
USD 2900.00 (Single User License)Global Dry Powder Inhalation Excipients Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1733 million in 2024 to US$ 2491 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 159
USD 4900.00 (Single User License)Global Dry Powder Inhalation Excipients Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dry Powder Inhalation Excipients market size was US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 92
USD 4250.00 (Single User License)Dry Powder Inhalation Excipients - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 127
USD 3950.00 (Single User License)Global Dry Powder Inhalation Excipients Market Research Report 2025
The global market for Dry Powder Inhalation Excipients was valued at US$ 1733 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-03-13
Pages: 97
USD 2900.00 (Single User License)Global and United States Dry Powder Inhalation Excipients Market Report & Forecast 2024-2030
The global Dry Powder Inhalation Excipients revenue was US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the review period (2024-2030).
Published: 2025-01-01
Pages: 133
USD 4350.00 (Single User License)Global Dry Powder Inhalation Excipients Market Research Report 2024
The global market for Dry Powder Inhalation Excipients was valued at US$ 1674 million in the year 2023 and is projected to reach a revised size of US$ 2376 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-01-01
Pages: 91
USD 2900.00 (Single User License)Dry Powder Inhalation Excipients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 117
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now